Moderna mRNA mpox vaccine shows promise in animal study

Phys.org  September 4, 2024 In 2022, mpox virus (MPXV) spread worldwide, causing 99,581 mpox cases in 121 countries. Modified vaccinia Ankara (MVA) vaccine use reduced disease in at-risk populations but failed to deliver complete protection. Lag in manufacturing and distribution of MVA resulted in additional MPXV spread, and an additional outbreak in Central Africa of clade I virus. A team of researchers in the US (United States Army Medical Research Institute of Infectious Diseases, industry, NIH, Boston University) tested mRNA-1769, an mRNA-lipid nanoparticle (LNP) vaccine expressing MPXV surface proteins, in a lethal MPXV primate model. Similar to MVA, mRNA-1769 conferred […]

The Big 3 Infectious Diseases Besides COVID-19 Scientists Are Trying to Find a Vaccine For

Global Biodefense  October 5, 2020 Researchers in Australia regard malaria, tuberculosis, and HIV/AIDS as the “big three” infectious diseases. Together they are responsible for about 2.7 million deaths a year around the world. Although anti-malarial drugs are routinely used to treat and prevent malaria infection, the emergence of multi-drug resistant tuberculosis is a major cause of death and a serious public health concern. Since the discovery of HIV in the 1980s, the disease has caused 33 million deaths. Some 38 million people have HIV/AIDS worldwide. There is currently no cure or protective vaccine. The current pandemic highlights the need for […]

Landmark recommendations on development of artificial intelligence and the future of global health

Science Daily  May 19, 2020 In this review article, a team of researchers in the US (Columbia University, Johns Hopkins University) suggests that AI-driven health interventions fit into four categories relevant to global health researchers: (1) diagnosis, (2) patient morbidity or mortality risk assessment, (3) disease outbreak prediction and surveillance, and (4) health policy and planning. However, much of the AI-driven intervention research in global health does not describe ethical, regulatory, or practical considerations required for widespread use or deployment at scale. Despite the field remaining nascent, AI-driven health interventions could lead to improved health outcomes in Low and Middle […]